Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer (With CNS Involvement)”

93 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 93 results

Early research (Phase 1)Study completedNCT03371004
What this trial is testing

DM-CHOC-PEN Plus Radiation for Brain Tumors

Who this might be right for
Advanced Cancer
DEKK-TEC, Inc. 19
Large-scale testing (Phase 3)Ended earlyNCT03326674
What this trial is testing

Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC

Who this might be right for
Breast Cancer
Odonate Therapeutics, Inc. 685
Testing effectiveness (Phase 2)UnknownNCT01593488
What this trial is testing

Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children

Who this might be right for
Acute Lymphoblastic Leukemia
National Cancer Institute, Naples 31
Testing effectiveness (Phase 2)Looking for participantsNCT07227610
What this trial is testing

Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)

Who this might be right for
Brain MetastasesCancer (With CNS Involvement)
Medical University of South Carolina 54
Testing effectiveness (Phase 2)Study completedNCT00025623
What this trial is testing

Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma

Who this might be right for
Neuroblastoma
European Infant Neuroblastoma Study Group - 1999
Testing effectiveness (Phase 2)WithdrawnNCT01736800
What this trial is testing

Phase II Trial of Chemotherapy With Temodar With Topotecan for CNS Metastasis of Solid Tumors

Who this might be right for
Central Nervous System (CNS) MetastasesBrain Metastases
The Methodist Hospital Research Institute
Testing effectiveness (Phase 2)Study completedNCT03668847
What this trial is testing

DM-CHOC-PEN for Brain Tumors in AYA Subjects

Who this might be right for
Advanced CancerBrain Metastases
DEKK-TEC, Inc. 20
Not applicableWithdrawnNCT01939483
What this trial is testing

A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases

Who this might be right for
Central Nervous System MetastasesMale Breast CancerRecurrent Breast Cancer+1 more
University of California, Irvine
Not applicableLooking for participantsNCT06292741
What this trial is testing

Autonomic Involvement in Patient With Cognitive Decline

Who this might be right for
Dementia, MildDementia of Alzheimer Type
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 120
Testing effectiveness (Phase 2)Ended earlyNCT03952325
What this trial is testing

Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC

Who this might be right for
Breast Cancer
Odonate Therapeutics, Inc. 294
Early research (Phase 1)Active Not RecruitingNCT04197934
What this trial is testing

WSD0922-FU for Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases

Who this might be right for
Anaplastic Astrocytoma, IDH-WildtypeGlioblastoma, IDH-WildtypeMetastatic Lung Non-Small Cell Carcinoma+2 more
Mayo Clinic 56
Testing effectiveness (Phase 2)WithdrawnNCT02724904
What this trial is testing

Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma

Who this might be right for
Lymphoma
Massachusetts General Hospital
Not applicableStudy completedNCT07239102
What this trial is testing

Firmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System Metastasis

Who this might be right for
EGFR Positive Non-small Cell Lung CancerCentral Nervous System MetastasisLeptomeningeal Metastasis
Beijing Tiantan Hospital 300
Early research (Phase 1)Ended earlyNCT03332589
What this trial is testing

E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS)

Who this might be right for
Malignant MelanomaBrain Metastases
Spirita Oncology, LLC 4
Early research (Phase 1)Ended earlyNCT05388877
What this trial is testing

E6201 and Dabrafenib for the Treatment of Central Nervous System Metastases From BRAF V600 Mutated Metastatic Melanoma

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Neoplasm in the Central Nervous System+1 more
Mayo Clinic 13
Testing effectiveness (Phase 2)Study completedNCT00098605
What this trial is testing

Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases

Who this might be right for
Central Nervous System MetastasesHER2-positive Breast CancerMale Breast Cancer+3 more
National Cancer Institute (NCI) 37
Not applicableUnknownNCT06352502
What this trial is testing

An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis

Who this might be right for
EGF-R Positive Non-Small Cell Lung CancerCNS Metastases
Tang-Du Hospital 30
Large-scale testing (Phase 3)UnknownNCT01813240
What this trial is testing

Prevention of Imminent Paralysis Following Spinal Cord Trauma or Ischemia by Minocycline: A Multi-center Study in Israel With IDF Primary Care Involvement

Who this might be right for
Spinal Tumors, Trauma Patients, Minocycline.
Hadassah Medical Organization 444
Not applicableStudy completedNCT00305617
What this trial is testing

Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
The Cleveland Clinic 10
Large-scale testing (Phase 3)Study completedNCT00048997
What this trial is testing

Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 356
Next Page